<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 342 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page341.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=342">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 342 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 342</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=342"><img src="../thumb/342.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>Endocrine System - 19.6.4 / 19.6.5                                             2020-04 / 305
       hist./curr.ven.thrombo-embol., curr./hist.of thrombophil.disords./   fact., hypertens., liv. disord., diab.mellit., cholelithias., migraine/  libido disord., vertigo, nervousn., uter.fibroid. alopec., acne, ven.
       thrombophlebit., curr./hist.of arter.thrombo-embol. dis., porphyr.,   sev. headache, SLE, endometr.hyperplas.hist., epilep., mastopathy,   thromboembol. Unknown: Endometr.hyperplas., hirsut., benign/
       CV dis.prevent., patch applic. to/near to breasts.  card./ren.dysfunct./liv.funct.disturbs., cholestat.jaund.hist., pre-exist.   malign.oestrog.depend.neoplasm,, MI, stroke, chloasma, erythema
       Side effects: Very common: Headache, applic. site reacts., breast   hypertriglyceridaem., discont.in case of: jaund./liv. funct. deteriorat./  multiforme/ nodosum, haemorrhag.erupt., vasc.purpura, dement.,
       pain/-tendern., dysmenorrh., menstr.disords. Common: Dizzin., de-  signif.BP incr./new-onset migraine-type headache/pregn., incr.breast   gen.hypersens.reacts incl.anaphylact. react./shock.
       press., nervousn., insomn., emot.lability, acne, rash, prurit., dry skin,   Ca risk, incr.ovar.Ca risk in hysterectom.women, incr. stroke/ coron.  Warnings and special precautions: Limit. exper. in women over 65
       back pain, pain in extrem., breast enlargem., mennorh., leukorrh.,   arter.dis./ven thrombo-embol.risk, recur. thromboembol./spontan.  yrs., no contracept.eff, investig.cause of spott.if occurs.some time on
       vag.haemorrh., uter. spasms, vaginit., endometr.hyperplas., pain,   abort.family hist., cons.benef./risk with concom.anticoag., prolong.   ther./aft.ther.discont., poss.incr.CV morbid.risk dur.1st year of ther., incr.
       asthen., weight gain, periph.oed. Uncommon: Migraine, ver-  immobilisat., maj.trauma, discont.4-6 wks.bef. plann. surg.& not   endometr.Ca/hyperplas./ breast & ovar.Ca/VTE/ischaem.stroke risk
       tigo, vomit., elev.transaminas., skin discolourat., breast Ca. Rare:   restart.until pt.mobilis., discont.if ven. thromboembol.devel.aft.init.  relat.to longt.oestrog., incr.circulat.total thyr.hormone/ corticoster./sex
       Ven. thromboembol., gallstones, gallbladd.dis., uter. leiomyomata,   ther., pt.to alert dr.of potent.thrombo-embol.sympt., incr.dement.   hormones, incr.risk of probable dement.in pts.&gt;65 start ther., full medic.
       paratubul.cysts, endocervic.polyps, allerg. reacts. libido changes,   risk, not for contracept.use, do not contin.ther. long. than 5 yrs.,   hist/exam. bef.init.ther., re-appraise risk-benefit ratio annually, ther.
       paraesthes. Very rare: Cholestat.jaund. Other: oestrog.depend.   do not apply on/near breasts, withdr.ther.immed.if pregn.occurs,   should not exceed 5 yrs., reg.breast exam./ mammogr.advoc., card./
       neoplasm, stroke, MI, dement.  concom. lamotrigine,        ren.dysfunct., discont. immed.in pres.of ven.or arter. thromboembol.
       Special precautions: Eval.benef.vs.risk of ther. & per.re-evaluat.  Drug interactions: Meds.induc.microsom.liv. enzyme activ.eg bar-  disords./arter.dis./jaund./liv.funct. deteriorat./ signif.BP incr./sudd.part.
       for cont.treatm.recomm., osteoporos., contact.sensitisat., poss.  bits./hydantoin/ carbamazep/ meprobam./phenylbutaz./rifampicin/  or complete loss of vis./sudd.proptos or diplop./new onset migraine-
       incr.CV dis./breast CA/ovar.Ca/endometr.Ca/dement./ VTE risk,   rifabut.& cert.non-nucleoside revers.transcript.poss. alt. oestrog.&   type headache & pregn., in pres.of/prev. occur. of/aggrav.by pregn.
       VTE prophylax.follow.surg./prolong. immobilisat., discont.if thro-  progest.metab., ritonavir/nelfinavir/St John’s Wort may decr.effs.,   or prev.HRT ther.to be closely supervis.in uter.fibroids./endometrios./
       mo-embol.sympt., recurr.spontan.abort.hist., poss.irreg.bleed.init.,   lamotrigine plasma conc.poss.decr.  thromboembol. disords./endometr.hyperplas./ hypertens./ liv.dis./diab.
       compl.medic./gynae.exam.bef.init.ther., reg. foll.up advis.dur.pro-  mellit.with vasc.involvem. / cholelithias./sudd.hear.loss/migraine or
       long.treatm., undiagn.vag. bleed./spott., breast screen.bef/reg.dur.  KLIOGEST, Novo Nordisk [P/S]  sev. headaches/SLE, reconsid.ther.in pres.of aggrav. asthma/ epilep./
       treatm. esp.in high risk cases, endometrios., pre-exist. leiomyomas/  Estradiol 2 mg, norethisterone acetate 1 mg.  diab.mellit., benef.vs.risk where ven. thromboembol.risk fact.exist,
       fibroids poss.enlarge, monit. endometrios., benef.-risk eval.if hyper-  Indications: Oestrog.defic.sympts. in women &gt;1 yr. aft. meno-  concom. anticoag. ther., VTE risk fact.eg.fam.hist.thereof/ obesity/
       tens./ asthma/ HF/ren.& hepat.disords./migraine/ epileps. worsen,   pause., reduc.bone loss risk in postmenopaus.women.  prolong. immobilisat./maj.trauma or surg., incr.risk of gallbladd.dis.,
       discont.if incr.seiz., oestrog.-relat. jaund.& prurit., discont.if cholest.  (S4) FILM COAT.TABS. Y/21.8.2/230.  elev.triglycer.plasma lev. in familial hypertriglyderidaem., reduc.gluc.
       jaund. develop., gallbladd.dis., hypertriglyceridaem., diab.  820024-007: 28, R308,02  tol. may affect insul/oral antidiabet.requirem., incr.risk of breast Ca/
       Interactions: Microsom.liv.enzyme-induc. e.g. barbits./anticon-  Dosage: 1 tab dly.without interrupt. Treatm.to be initiated 1 yr.  endomet.Ca in relat.to HRT durat.as describ.in WHI studies, lact.intol.
       vuls./meprobrom./phenylbutaz. /cert.antibiot.incl.rifampicin may   aft.menopause.  Interactions: Metabol.incr.by drugs.induc.drug-metabol. enzymes
       imp.oestrog.& progest.activ.  Contraindications: Pregn., lactat., known/ suspect. breast Ca/oes-  (cytochrome P450 enzymes) eg. phenobarbit./ phenytoin/car-
       See also MDR page 83.         trog.depend.neoplas., ac./chron.liv.dis., undiagn.vag.bleed., untreat.   bamezap./anti-infect./ rifampic./rifabutin/nevirapine & efavirenz., St
                                     endometr. hyperplas., endometrios., thrombophlebit./ thromboem-
       ESTRO-PAUSE N, AI Pharm Ltd [P/S]  bol.disords., CV dis., porphyr.,   John’s Wort induc.metabol., decr.hepat.excret.of concom. ciclospor.
       16 grey blue tablets: oestradiol valerate 1 mg, 12 white tablets:   Side effects: Very common: Breast pain/ tendern., irreg. men-  POSTOVAL, (Aspen Pharmacare: Pharma) Pharmacare [P/S]
       oestradiol valerate 1 mg & norethisterone 1 mg.  struat./ haemorrh. Common: Genit. candidias., vaginit., fluid retent.,   11 white tabs: oestradiol valerate 2 mg, 10 orange tabs: oestradiol
       Indications: Hormon.replacem.therapy for menopaus.sympts.  depress./ aggravat.of, headache, migraine/aggravat.of, naus., ab-  valerate 2 mg, norgestrel 0,5 mg, 7 red placebo tabs.
       (S4) TABS. 29/21.8.2/0763.    dom. pain/-distens./-discomf., leg cramps., back pain, breast oed./-  Indications: Cycle disturb.regulat., vasomot.& autonom.nervous
       822493-004: 28, R133,84       enlargem., uter. fibroids/ aggravat.of/ reoccurr., periph.oed., incr.   syst.sympts.caus.by oestrogen decline, depress., irritab.& anx.as-
       Dosage: Start at any time of cycle, but if menstr. regul.beg.on 1st   weight. Uncommon: Breast Ca, hypersens., nervousn., superfic.  soc.with peri/ postmenopaus.state.
       day of bleed. Take one tablet dly. as direct.on 28 day calendar pack.  thrombo phlebit., flatul., bloat., alopec., hirsute., acne, prurit., urticar.,   (S4) TABS. K/21.8.2/289.
       Use low.dos.compat.with sympt.contr.  med. ineffect. Rare: Deep thrombophlebit., pulm.embol. Unknown:   825980-003: 28, R194,93
       Contraindications: Fam./person.breast or genit. tract malign.ne-  Benign/ malign.oestrog.-depend. neoplasms e.g. endometr.Ca, in-  Dosage: 1 tab dly for 28 days, start 1st day of menstr.cycle.
       oplast.dis.hist., prev.thrombo-embol. disords., CV/ kidn.dis., throm-  somn., anx, libido changes, dizzin., stroke, vis.disturbs., aggravat.   Contraindications: Mark.imp.hepat.funct., Dubin-Johnson/Ro-
       bophlebit., undiagn.vag.bleed., herpes gestation., endometrios., liv.  hypertens., dyspeps., vomit., gallbladd.dis, stroke, cholelithiasis/   tor syndr., cholestat.jaund., exist./ treat. Ca-breast, congenit.lipid
       impairm., Dubin Johnson/Rotor syndr., cholestat.jaund., sickle-cell   aggravat of/ re-occurr., seborrh, rash, angioneurot.oed., endometr.  metabol.disturbs., pregn., otoscleros.with deteriorat.dur.pregn.,
       anaem., persist. itch.dur.prev.pregn., otoscleros that deteriorat.due   hyperplas., vulvovag. prurit., MI, stroke, decr.weight,incr. BP, chlo-  endometr. Ca & undiagn.vag.bleed., cerebr.vasc./ coron. artery dis.,
       to pregn., diab.mellit.hist., epilep., asthma, hypertens., depress.,   asma, erythema multiforme/nodosum, vasc. purpura, alterat. in liv.  thrombophlebit./ thromboembol. disords.
       porphyr., fluid retent.states., pregn.& lactat., premenopaus.women.  funct, jaund., decr.gluc.tol., decr. contact lens.toler.  Side effects: Init.spot.& breakthrough bleed., naus., headache,
       Side effects: GI disturbs., skin & hair chang., headache, water re-  Warnings and special precautions: Limit. exper.in women old.  breast tendern., changes in libido.
       tent., appet./weight chang., breast tendern., libido & menstr.chang.,   than 65 yrs., not indic.as contracept., compl.physic./med./fam.hist.  Special precautions: Hypertens., not a contracept., if withdr.
       depress./ ment.chang., cont.lens intol., incr.risk of thrombo-embol.&   bef.ther. init./re-institut. & reg.exam.dur.treatm., reg.breast exam./   bleed.fails to occur, test for pregn., fam.breast dis.hist., gall bladd.
       CV dis.in pts.with risk fact.  mammogram advoc., period.eval.risk vs benef. of women tak.HRT,   dis., diabet., endometrios., lact.intol., cont.sucrose
       Special precautions: Excl.pregn.bef.init.ther., thorough gynae./  abnorm.bleed.of unknown aetiology /those prev.treat.with unoppos.
       physic.exam.advis.bef.init.ther.& period.dur.ther., restrict use to 6   oestrog.with intact uter.to be examin.carefully for poss. hyperstimu-  TRISEQUENS, Novo Nordisk [P/S]
       mnths.post-menopause, irreg.bleed.usually trans., reg.breast exam.,   lat./endometr.malign., breast Ca risk incr.with numb.of yrs.of HRT   12 Blue tabs: estradiol 2 mg, 10 white tabs: estradiol 2 mg, nore-
       monit.pts. suffer.from condits.subj.to deteriorat.dur.pregn.& endo-  use, endometr. hyperplas.& endometr.Ca risk incr.with prolong. ad-  thisterone acetate 1 mg, 6 red tabs: estradiol 1 mg.
       metrios., discont.in pres. of migraine/unusual.sev.headaches, where   min.of oestrog alone, investig.breakthrough bleed./ spott.aft.some   Indications: Oestrogen defic.esp.intact.uterus., adjunct in prevent.
       thrombos.risk pres.or if jaund.occurs, monit.liv. funct.in cases of mild   time on ther.or aft.ther. discont., VTE risk fact.eg.fam.hist.thereof/  oestrog.defic.relat.post-menopaus. osteoporos.
       chron.liv.dis.& cholelithias., Dubin Johnson/Rotor syndr., take adeq.  obesity/ SLE/prolong.immobilisat./maj.trauma or surg., discont. ther.  (S4) FILM COAT.TABS, J/21.8.2/212.
       non-horm. contracept.meas.    if VTE devel., incr.ovar.Ca risk.in hysterectom. women on long term   825913-004: 28, R236,31
                                                                                  st
                                     oestrog.-only HRT, card.& ren. dysfunct.due to fluid retent. potent.,   Dosage: With reg.menstruat.take 1  tab on day aft. last day of
       EVOREL, Janssen Pharmaceutica [P/S]  pre-exist.hypertriglyceridaem.as incr. plasma triglycerid.lead.to pan-  menstr.bleed. Take 1 tab.at same time dly.
       Estradiol hemihydrate 50 µg, norethisterone acetate 170 µg/24 hrs.  creatit.report., uter. fibroids, endometrios., oestrog.depend.tumour   Contraindications: Pregn., Ca breast or oestrog. depend.neop-
       or Estradiol hemihydrate 3,2 mg, norethisterone acet.11,2 mg/patch.  risk fact.eg 1  degr.breast Ca line, hypertens., liv. disords., diab.mel-  las., ac./chron./hist.of liv.dis., undiagn. vag.bleed., thrombophle-
                                          st
       Indications: Hormon.replacem.ther. of menopaus. sympt.in women   lit., cholelithias., migraine or sev. headache, SLE, endometr.hyper-  bit., thromboembol. disords., cerebr.apoplex., hypertens., porphyr.,
       with an intact uterus.        plasia hist., epilep., asthma, otoscleros., card.fail., incr.circulat.total   haemoglobinopathies.
       (S4) TDS CONTI PATCH, [P/S] 31/21.8.2/0537.  thyroid hormone/corticoster./sex hormones, restrict use for bone min.  Side effects: Breast tens., headache, spott./ breakthrough bleed.,
       837873-002: 8, R345,36        content loss prevent. to women at incr.fract.risk, lact.intol, do not   oed., naus., depress., thromboembol., weight changes, incr.ser.lipids,
       Dosage: Apply 2x/wk without interrupt.on to clean / healthy/ in-  prescribe &gt; 1 yr.without repeat.physic.exam.incl. gynaecolog. exam.,   incr.BP/aggrav.of hypertens., fluid retent.
       tact/ dry skin on the trunk below the waist. Rotate applic.site with   discont.immed.in jaund./liv.funct. deteriorat./ signif.BP incr./sudd.vis.  Warnings and special precautions: No contracept. eff., vag.
       interv.of at least 1 wk       disturbs./new onset migraine-type headache & pregn., forgott. dos.   adenos.& cerv.adeno-Ca (in post pubert.girls.whose mothers were
       (S4)SEQUI TDS PATCH. [P/S] 31/21.8.2/0538.  may incr.likelihood of breakthrough bleed.& spott.  treat. with large dos.of Stilboestrol/relat.oestrog.cmpds. dur. pregn.),
       4x Evorel 50 TDS’s of estradiol 50 µg/24 hrs & 4x Evorel Conti TDS’s of   Interactions: Metabol.acceler.by drugs.induc. hepat.microsom.me-  incr.incid.endometr.uter.Ca with unoppos. oestrog., excl.poss.breast/
       estradiol hemihydrate 50 µg, norethisterone acetate 170 µg/24 hrs.  tabol.enzym.specif.cytochrome P450 eg.barbit./phenytoin/rifampicin   genit.tumours bef. start. treatm., reg.examinat.advis.dur.treatm.,
       837865-018: 8, R336,60        or carbamazepine, St John’s Wort may induc. metabol., poss. induc.  seek med. advice if S/E persist/intens., epilep., migraine, diabet.,
       Dosage: Use low.effect.dos. Apply 2x/wk.every 3-4 days without   eff.with ritonavir/telaprevir/ nelfinavir, circul.lev.incr.by drugs inhibit.  asthma, card.dysfunct., discont.immed.if thrombophlebit., throm-
       interrupt.on clean/dry/healthy/ intact area of skin to the trunk be-  hepat. microsom. metabol.enzymes eg.ketoconazole  boembol.disords./jaund./ sudd. vis.disturbs./migraine headaches/
       low the waist individ. 4x Evorel 50’s then 4 Evorel Conti ensur. corr.   incr.BP develop., withdr.4-6 wks.bef.plann.surg.& dur. hospitalisat.
       sequence. Rotate applic.site with interv.of at least 1 wk.  NOVOFEM, Novo Nordisk [P/S]  aft.trauma, cyclic.admin.with progestogens dur.long-term treatm.to
       Contraindications: Known curr./past/susp. breast Ca, known/  16 red tabs.: Estradiol 1 mg. 12 white tabs: estradiol 1 mg, nore-  avoid/reduc. poss. overstimulat., lact.intol.
       susp.oestrog.depend.malign./ pre-malign.tumours, undiag.genit.  thisterone 1 mg
       bleed., pregn.& lactat., act.liv.dis./liv.dis.hist.as long as liv.funct. test   Indications: Oestrog.defic.sympts.in postmenopaus. women with
       results not return.to norm., prev./curr.venous thrombo-embol., known   intact uterus, reduct. of bone loss risk in postmenopaus.women.
       thrombophil.condits., act./ past arter. thrombo-embol.dis., porphyr.  (S4) TABS, 37/21.8.2/0297  19.6.5  Other
       Side effects: Hypersens., psych.disords., headache, paraesthes.,   704903-001: 28, R197,83
       palpitat., hypertens., vasodilat., varicose veins, GI disturbs.incl.  Dosage: 1 tab dly.x28 days. Switch.to high.dos. ther. if respons.  EVISTA, Eli Lilly (SA) (Pty) Ltd
       abd.pain, erythemat.skin rash, arthralg., back pain, menstr. dis-  aft.3 mnths.not satisfact., menstruat.-like bleed. usually occ.at   See Section 4.7.2
       ords., breast pain/-enlargem., metrorrhag., genit. discharg., cerv.  beginn.of a new treatm.cycle., forgett.a dos.may incr. likelihood of
       polyp, dysmennorh., endometr. hyperplas., menorrhag., applicat.  breakthrough bleed.& spott.  LIVIFEM, MSD
       site react., oed., fatig., pain, weight incr., decr.libido, prurit., gen.oed.,   Contraindications: Known/suspect.breast Ca/ oestrog.depend.  Tibolone
       genit. candidias., breast Ca, dizzin., epilep., ven.& arter.thrombos.&   malign.tumours, breast Ca hist., undiagn. genit.bleed., curr./prev.  Indications: Sympt.treatm.of hot flushes & assoc. sweat.from nat./
       embol., skin rash, myalg., breast neoplasms, endometr.Ca, CVA,   idiopath.ven. thromboembol., act./rec.arter.thromboembol. events,   surgic.menopause, prev.of postmenopaus.osteoporos., improv.bone
       cholelithias., Stev.Johns.syndr.,  ac./hist.of liv.dis.so long as LFT not return. to norm., porphyr., untreat.  mineral density in pts.with est.PM osteoporos.
       Warnings and special precautions: Reg.gynae. exam.&. bef.   endometr.hyperplas., known/ suspect.pregn., lactat.  (S4) TABS, V/21.5.4/55
       init.ther., med./famil.hist.of ven./ arter. thrombophlebit./throm-  Side effects: Freq: Oed., vag.candidias., weight incr., headache,   797111-019: 2,5 mg, 28, R447,95
       bo-embol.disords., eval. rep.breakthr.bleed/unexpect.vag.bleed   dizzin., insomn., depress., breast tendern., vag. haemorrh., uter.fi-  Dosage: 1 tab.dly.swall.whole pref.at the same time dly. If dos.
       & chang. notic.dur.breast.exam., cons.benef./risk bef. init.ther.,   broids aggrav., rash. prurit., incr.BP, aggravat.hypertens. Less freq:   is miss.& more than 12 hrs.overdue it should be skip.& the next
       leiomyoma, thromboembol.disord./ oestrog.depend.tumour risk   Gallbladd.dis., gallstones, allerg.react., musc. cramps, migraine,   dos.tak.at norm.time.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page341.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page337.html">337</a>&nbsp;&nbsp;&nbsp;<a href="page338.html">338</a>&nbsp;&nbsp;&nbsp;<a href="page339.html">339</a>&nbsp;&nbsp;&nbsp;<a href="page340.html">340</a>&nbsp;&nbsp;&nbsp;<a href="page341.html">341</a>&nbsp;&nbsp;&nbsp;<a href="page342.html">342</a>&nbsp;&nbsp;&nbsp;<a href="page343.html">343</a>&nbsp;&nbsp;&nbsp;<a href="page344.html">344</a>&nbsp;&nbsp;&nbsp;<a href="page345.html">345</a>&nbsp;&nbsp;&nbsp;<a href="page346.html">346</a>&nbsp;&nbsp;&nbsp;<a href="page347.html">347</a>
             </td>
             <td width="35%"><a href="page343.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page343.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
